<DOC>
	<DOC>NCT00759174</DOC>
	<brief_summary>The objective of this non-interventional study is to examine whether use of Phosphodiesterase Inhibitors (PDE5s), including use of sildenafil, vardenafil, or tadalafil, triggers the onset of acute NAION.</brief_summary>
	<brief_title>A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION</brief_title>
	<detailed_description>Sites will identify patients who meet the entry criteria during the conduct of their normal practice. Patients meeting these criteria will be offered participation in the study after reading and completing an informed consent document.</detailed_description>
	<mesh_term>Optic Nerve Diseases</mesh_term>
	<mesh_term>Optic Neuropathy, Ischemic</mesh_term>
	<mesh_term>Phosphodiesterase 5 Inhibitors</mesh_term>
	<criteria>Male aged â‰¥45 years; Experienced abrupt visual change in only 1 eye Pain determined by an ophthalmologist to be consistent with an inflammatory/arteritic process or optic neuritis; History of NAION or optic neuritis. Participation in other studies within 60 days prior to entry in the study.</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Optic Neuropathy Acute NAION PDE5 Inhibitor</keyword>
</DOC>